|
Feb 15
|
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023
|
|
Jan 10
|
Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older
|
|
Jan 8
|
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
|
|
Dec 21
|
Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 18
|
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines
|
|
Apr 27
|
Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for
|